The nanomedicine revolution: Part 1: Emerging Concepts

P and T

Volumn 37, Issue 9, 2012, Pages

  Lee Ventola, C ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; CARBON NANOTUBE; DAUNORUBICIN; DIAGNOSTIC AGENT; DOXORUBICIN; LIPOSOME; NANOSHELL; POLYMER; QUANTUM DOT; SUPERPARAMAGNETIC IRON OXIDE;

ARTICLE; BIOAVAILABILITY; CONJUGATION; DRUG DELIVERY SYSTEM; DRUG TARGETING; HUMAN; KAPOSI SARCOMA; MYCOSIS; NANOMEDICINE; NANOTECHNOLOGY; OVARY CANCER;

EID: 84866924189     PISSN: 10521372     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Poirot-Mazères I. Legal aspects of the risks raised by nanotechnologies in the field of medicine. J Int Bioethique 2011;22(1):99-118+212.
2. Bawa R. Regulating nanomedicine-can the FDA handle it? Curr Drug Deliv 2011;8(3):227-234.
3. Galvin P, Thompson D, Ryan KB, et al. Nanoparticle-based drug delivery: Case studies for cancer and cardiovascular applications. Cell Mol Life Sci 2012;69(3):389-404.
4. Bharali DJ, Mousa SA. Emerging nanomedicines for early cancer detection and improved treatment: Current perspective and future promise. Pharmacol Ther 2010;128(2):324-335.
5. Sajja HK, East MP, Mao H, et al. Development of multifunctional nanoparticles for targeted drug delivery and noninvasive imaging of therapeutic effect. Curr Drug Discov Technol 2009;6(1):43-51.
6. Seigneuric R, Markey L, Nuyten DS, et al. From nanotechnology to nanomedicine: Applications to cancer research. Curr Mol Med 2010;10(7):640-652.
7. Bhaskar S, Tian F, Stoeger T, et al. Multifunctional Nanocarriers for diagnostics, drug delivery and targeted treatment across blood-brain barrier: Perspectives on tracking and neuroimaging. Part Fibre Toxicol 2010;3;7:3.
8. McGrady E, Conger S, Blanke S, Landry BJ. Emerging technologies in healthcare: Navigating risks, evaluating rewards. J Healthcare Manag 2010;55(5):353-364.
9. Godin B, Sakamoto JH, Serda RE, et al. Emerging applications of nanomedicine for the diagnosis and treatment of cardiovascular diseases. Trends Pharmacol Sci 2010;31(5):199-205.
10. What is nanotechnology? National Nanotechnology Initiative. Available at: www.nano.gov/nanotech101/what/definition. Accessed June 7, 2012.
11. What's so special about the nanoscale? National Nanotechnology Initiative. Available at: www.nano.gov/nanotech-101/special. Accessed June 7, 2012.
12. Nanotechnology. FDA Science & Research. Available at: www.fda.gov/ScienceResearch/SpecialTopics/Nanotechnology/default.htm. Accessed June 7, 2012.
13. Fact Sheet: Nanotechnology. FDA Guidance, Compliance, & Regulatory Information. Available at: www.fda.gov/Food/GuidanceComplianceRegulatoryInformation/GuidanceDocuments/ucm300914.htm. Accessed June 7, 2012.
14. FDA continues dialogue on 'nano' regulation. FDA for Consumers. Available at: www.fda.gov/ForConsumers/ConsumerUpdates/ucm258462.htm. Accessed June 7, 2012.
15. FDA readies for more Nanoscale' challenges. FDA Science & Research, July 25, 2007. Available at: www.fda.gov/ScienceResearch/SpecialTopics/Nanotechnology/ucm153723.htm. Accessed June 7, 2012.
16. FDA Nanotechnology Task Force Report outlines scientific, regulatory challenges. Available at: www.fda.gov/ForConsumers/ConsumerUpdates/ucm110934.htm?utm_campaign=Google2&utm_source=fdaSearch&utm_medium=website&utm_term=nanomedicine&utm_content=1. Accessed June 7, 2012.
17. Taylor E, Webster TJ. Reducing infections through nanotechnology and nanoparticles. Int J Nanomed 2011;6:1463-1473.
18. Nanotechnology Task Force. FDA Science & Research. Available at: www.fda.gov/ScienceResearch/SpecialTopics/Nanotechnology/NanotechnologyTaskForce/default.htm. Accessed June 7, 2012.
19. Good news for nanomedicine: Quantum dots appear safe in pioneering study on primates. Science News, May 20, 2012. Available at: www.sciencedaily.com/releases/2012/05/120520133919.htm. Accessed June 7, 2012.
20. Vaddiraju S, Tomazos I, Burgess DJ, et al. Emerging synergy between nanotechnology and implantable biosensors: A review. Biosens Bioelectron 2010;25(7):1553-1565.
21. Ferrari M. Cancer nanotechnology: Opportunities and challenges. Nat Rev Cancer 2005;5(3):161-171.